Brian Schwartz
Director Técnico/Científico/I+D en INTENSITY THERAPEUTICS, INC. .
Fortuna: 46 596 $ al 31/05/2024
Cargos activos de Brian Schwartz
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Director/Miembro de la Junta | 01/12/2020 | - |
| CYCLACEL PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 17/12/2020 | - |
| Director Técnico/Científico/I+D | 25/01/2024 | - | |
| Independent Dir/Board Member | 17/12/2020 | 25/01/2024 | |
| INTENSITY THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Brian Schwartz
Antiguos cargos conocidos de Brian Schwartz.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 07/09/2021 | 24/07/2023 |
| MEREO BIOPHARMA GROUP PLC | Director/Miembro de la Junta | 01/10/2020 | 10/11/2022 |
| VINCERX PHARMA, INC. | Director/Miembro de la Junta | 05/03/2020 | 23/12/2020 |
| Independent Dir/Board Member | 05/03/2020 | 23/12/2020 | |
| ARQULE, INC. | Director Técnico/Científico/I+D | 01/06/2008 | 01/03/2020 |
| ALAUNOS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2008 | - |
| Consejero General | 01/01/2008 | - |
Formación de Brian Schwartz.
| University of Pretoria | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Sudafrica | 2 |
| Reino Unido | 2 |
Operativa
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 2 |
Sectorial
| Health Technology | 8 |
| Consumer Services | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
- Bolsa de valores
- Insiders
- Brian Schwartz
- Experiencia
